Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Hodgkin's lymphoma can show up as hair loss.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Single-cell sequencing shows that different types of macrophages have unique roles in wound healing.

A parasite molecule can speed up skin healing and reduce scarring.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Iron deficiency is not a significant cause of hair loss in women.

Early diagnosis and treatment are crucial for managing Folliculotropic Mycosis Fungoides on the scalp.

Dr. WP Unger suggested that traditional strip harvesting might be better for hair transplants than Follicular Unit Extraction due to higher hair survival rates and less risk of a patchy look at the donor site.

Follicular Unit Extraction (FUE) for hair transplants has limitations and may not be suitable for most patients.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

Boosting HGF signaling could improve the creation of hair follicles in lab-made skin.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Mammalian organs regenerate using stem cells and cell plasticity, but this ability declines with age.

Mechanical stretching of the skin can promote hair growth by activating certain immune cells.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.